The rapid rise of targeted drugs and biologics in oncology has spurred sponsors and the FDA to innovate, leading to the creation of a variation to the typical trial design that can include multiple expansion cohorts.
Andrew Kinley, Ph.D.
Advertisement
Articles by Andrew Kinley, Ph.D.
Advertisement
Latest Updated Articles
Multiple Expansion Cohort Clinical Trials: A Shorter Path to Success for Oncology DrugsPublished: November 27th 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
2
Redefining CRA Workflows Through Intelligent Automation
3
Applied Clinical Trials' 2025 State of the Industry Survey
4
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
